Tetra Bio-Pharma Overview
- Year Founded
-
2007
- Status
-
Public
- Employees
-
39
- Stock Symbol
-
TBPMQ
- Investments
-
8
Tetra Bio-Pharma General Information
Description
Tetra Bio Pharma Inc is a biopharmaceutical leader in cannabinoid-based drug. It discovers and develops clinical programs aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. The company with its subsidiaries engaged in the development of an advanced and growing pipeline of Bio Pharmaceuticals and Veterinary Products containing cannabinoids. Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies.
Contact Information
Website
www.tetrabiopharma.comCorporate Office
- 2316 Saint Joseph Boulevard
- Orleans, Ontario K1C 1E8
- Canada
Corporate Office
- 2316 Saint Joseph Boulevard
- Orleans, Ontario K1C 1E8
- Canada
Tetra Bio-Pharma Timeline
Tetra Bio-Pharma Stock Performance
As of 19-Jan-2024, Tetra Bio-Pharma’s current market cap is $84.7K.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $84.7K | 284K | -$0.06 |
Tetra Bio-Pharma Financials Summary
As of 31-Aug-2022, Tetra Bio-Pharma has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 31-Aug-2022 | FY 2021 30-Nov-2021 | FY 2020 30-Nov-2020 | FY 2019 30-Nov-2019 |
|---|---|---|---|---|
| EV | 19,727 | 64,932 | 31,703 | 55,124 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (30,213) | (40,078) | (15,775) | (9,885) |
| Net Income | (30,653) | (41,594) | (19,686) | (11,494) |
| Total Assets | 2,306 | 5,926 | 22,595 | 21,497 |
| Total Debt | 1,268 | 2,442 | 1,540 | 0 |
Tetra Bio-Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Tetra Bio-Pharma Comparisons
Industry
Financing
Details
Tetra Bio-Pharma Competitors (8)
One of Tetra Bio-Pharma’s 8 competitors is Oxford Cannabinoid Technologies, a Formerly VC-backed company based in Oxford, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Oxford Cannabinoid Technologies | Formerly VC-backed | Oxford, United Kingdom | ||||
| Lotus Cannabis Company | Corporation | Vancouver, Canada | ||||
| Quantum BioPharma | Corporation | Toronto, Canada | ||||
| Revive Therapeutics | Corporation | Toronto, Canada | ||||
| Repare Therapeutics | Formerly VC-backed | Montreal, Canada |
Tetra Bio-Pharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Tetra Bio-Pharma Patents
Tetra Bio-Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230271908-A1 | Methods, processes, and compositions for improved preparation of hu308 and hu433 | Active | 24-Sep-2020 | ||
| US-12129227-B2 | Methods, processes, and compositions for improved preparation of hu308 and hu433 | Active | 24-Sep-2020 | ||
| CA-3027876-A1 | Cannabis compositions and methods | Inactive | 18-Dec-2018 | ||
| US-20220054447-A1 | Cannabis compositions and methods | Inactive | 18-Dec-2018 | ||
| AU-2019409889-A1 | Cannabis compositions and methods | Inactive | 18-Dec-2018 | A61K31/352 |
Tetra Bio-Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Tetra Bio-Pharma Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Tetra Bio-Pharma Investments & Acquisitions (8)
Tetra Bio-Pharma’s most recent deal was a Corporate with TALLC (Drug Discovery). The deal was made on 03-Jun-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| TALLC (Drug Discovery) | 03-Jun-2020 | Corporate | Drug Discovery | ||
| CB2 Therapeutics | 21-Aug-2019 | Joint Venture | Pharmaceuticals | ||
| Panag Pharma | 01-May-2019 | Merger/Acquisition | Drug Discovery | ||
| Joint Venture (Tetra Bio-Pharma and Altus Formulation) | 29-Apr-2019 | Joint Venture | Drug Delivery | ||
| Phytopain Pharma | 19-Mar-2018 | Secondary Transaction - Private | Pharmaceuticals |
Tetra Bio-Pharma Exits (2)
Tetra Bio-Pharma’s most recent exit was on 22-Jun-2016 from Holizen. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Holizen | 22-Jun-2016 | Completed |
|
||
| Export Hydro | 06-Nov-2015 | Merger/Acquisition | Completed |
Tetra Bio-Pharma Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Targeted Pharmaceuticals | Marlborough, MA | 2018 | |
| Panag Pharma | Halifax, Canada | 2014 |
Tetra Bio-Pharma FAQs
-
When was Tetra Bio-Pharma founded?
Tetra Bio-Pharma was founded in 2007.
-
Where is Tetra Bio-Pharma headquartered?
Tetra Bio-Pharma is headquartered in Orleans, Canada.
-
What is the size of Tetra Bio-Pharma?
Tetra Bio-Pharma has 39 total employees.
-
What industry is Tetra Bio-Pharma in?
Tetra Bio-Pharma’s primary industry is Drug Discovery.
-
Is Tetra Bio-Pharma a private or public company?
Tetra Bio-Pharma is a Public company.
-
What is Tetra Bio-Pharma’s stock symbol?
The ticker symbol for Tetra Bio-Pharma is TBPMQ.
-
What is the current market cap of Tetra Bio-Pharma?
The current market capitalization of Tetra Bio-Pharma is $84.7K.
-
Who are Tetra Bio-Pharma’s competitors?
Oxford Cannabinoid Technologies, Lotus Cannabis Company, Quantum BioPharma, Revive Therapeutics, and Repare Therapeutics are some of the 8 competitors of Tetra Bio-Pharma.
-
What is Tetra Bio-Pharma’s annual earnings per share (EPS)?
Tetra Bio-Pharma’s EPS for 12 months was -$0.06.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
